SCHEMBL29907196

SCHEMBL29907196

COc1cc2c(cnn2C(c2ccccc2)(c2ccccc2)c2ccccc2)nc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.35
SRC P12931 1/20 0.35
CYP19A1 P11511 1/20 0.34
NQO2 P16083 1/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
ACSS2 Q9NR19 3/20 0.33
ADA P00813 1/20 0.33
PDE10A Q9Y233 1/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
KCNA5 P22460 1/20 0.32
PGK1 P00558 1/20 0.32
LCK P06239 1/20 0.32
LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23211069 1.00 FGFR1 (0.35) FGFR1SRCCYP19A1NQO2ALDH1A1
SCHEMBL23211080 0.91 ACSS2 (0.33) ACSS2
SCHEMBL23210728 0.86 ACSS2 (0.39) MAPTACSS2POLBSMN1; SMN2LMNA
SCHEMBL23236623 0.86
SCHEMBL23211141 0.84 GRIN1 (0.32)
SCHEMBL29907123 0.77 CTSA (0.37) ALDH1A1MAPTPDE10ASMN1; SMN2GAA
SCHEMBL23211040 0.77 CTSA (0.37) ALDH1A1MAPTPDE10ASMN1; SMN2GAA
SCHEMBL19949833 0.77 NPSR1 (0.40) ALDH1A1SMN1; SMN2
SCHEMBL23210808 0.76 PDE2A (0.34) ALDH1A1ACSS2PDE10ASMN1; SMN2GAA
SCHEMBL29907029 0.76 PDE2A (0.34) ALDH1A1ACSS2PDE10ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115835908-A Bicyclic heterocycles as FGFR inhibitors 因赛特公司 2023-03-21 CN disclosed
EP-4045151-A1 BICYCLIC HETEROCYCLES AS FGFR INHIBITORS Incyte Corporation (US) 2022-08-24 EP disclosed